⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8506926 | 0.81 | — | — | |
| SCHEMBL7967519 | 0.78 | TSHR (0.33) | — | |
| SCHEMBL1720228 | 0.74 | — | — | |
| SCHEMBL1403898 | 0.72 | MEN1 (0.43) | — | |
| SCHEMBL9579552 | 0.72 | MEN1 (0.36) | — | |
| SCHEMBL35561 | 0.72 | MEN1 (0.50) | — | |
| Alcohol SCHEMBL28322766 | 0.72 | TSHR (0.40) | — | |
| SCHEMBL1404086 | 0.70 | MEN1 (0.42) | — | |
| SCHEMBL1403899 | 0.70 | MEN1 (0.42) | — | |
| SCHEMBL1619600 | 0.70 | MEN1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230381732-A1 | NANOPARTICLE TEMPLATES AND METHODS OF USE FOR MAKING HOLLOW NANOPARTICLES | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2023-11-30 | — | — | US | claimed |
| CN-102464599-A | Amido methyl xanthogenic acid cyanoethyl ester compound, preparation method and collecting agent thereof | NORTHWEAT RES INST OF MINING & METALLURG INST | 2012-05-23 | — | — | CN | claimed |
| US-20230381732-A1 | NANOPARTICLE TEMPLATES AND METHODS OF USE FOR MAKING HOLLOW NANOPARTICLES | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2023-11-30 | — | — | US | disclosed |
| CN-115867533-A | Tryptamine prodrugs | 加拿大瑞安神经科学公司 | 2023-03-28 | — | — | CN | disclosed |
| US-11273168-B2 | Methods of treating anxiety by administering a substituted quinolone | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2022-03-15 | — | — | US | disclosed |
| US-20200281951-A1 | HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORDERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-09-10 | — | — | US | disclosed |
| CN-111574351-A | Long-wavelength hydroxymethyl phenyl ketone photoinitiator and preparation method thereof | 北京化工大学常州先进材料研究院 | 2020-08-25 | — | — | CN | disclosed |
| CN-111574352-A | Long-wavelength carbonyl alcohol photoinitiator and preparation method thereof | 北京化工大学常州先进材料研究院 | 2020-08-25 | — | — | CN | disclosed |
| US-10603331-B2 | Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-03-31 | — | — | US | disclosed |
| EP-2589701-B1 | METHOD FOR PRODUCING SIZING AGENT-COATED CARBON FIBERS, AND SIZING AGENT-COATED CARBON FIBERS | TORAY INDUSTRIES (JP) | 2019-08-21 | — | — | EP | disclosed |
| US-20190142852-A1 | HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-05-16 | — | — | US | disclosed |
| EP-0641321-A1 | SUBSTITUTED ISOINDOLONES | BASF Aktiengesellschaft (DE) | 1995-03-08 | — | — | EP | disclosed |
| WO-1993024456-A1 | SUBSTITUTED ISOINDOLONES | BASF AKTIENGESELLSCHAFT (DE) | 1993-12-09 | — | — | WO | disclosed |
| US-5190640-A | Sweetening sour oils and gases | BAKER HUGHES INCORPORATED (US) | 1993-03-02 | — | — | US | disclosed |
| EP-0227795-A4 | METHOD FOR PERFORMING NUCLEIC ACID HYBRIDIZATION ASSAYS. | AMGEN (US) | 1989-01-26 | — | — | EP | disclosed |
| EP-0224578-A4 | COMPOSITIONS AND METHODS FOR FUNCTIONALIZING NUCLEIC ACIDS. | AMGEN (US) | 1987-10-19 | — | — | EP | disclosed |
| EP-0227795-A1 | METHOD FOR PERFORMING NUCLEIC ACID HYBRIDIZATION ASSAYS. | AMGEN (US) | 1987-07-08 | — | — | EP | disclosed |
| EP-0224578-A1 | COMPOSITIONS AND METHODS FOR FUNCTIONALIZING NUCLEIC ACIDS. | AMGEN (US) | 1987-06-10 | — | — | EP | disclosed |
| WO-1986007363-A1 | COMPOSITIONS AND METHODS FOR FUNCTIONALIZING NUCLEIC ACIDS | AMGEN (US) | 1986-12-18 | — | — | WO | disclosed |
| WO-1986007387-A1 | METHOD AND KIT FOR PERFORMING NUCLEIC ACID HYBRIDIZATION ASSAYS | AMGEN (US) | 1986-12-18 | — | — | WO | disclosed |